News and Announcements
NE Banken Gold Mineralisation Sustainability Extended at Depth
- Published April 21, 2021 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Highlights
- Further results from 4 Diamond Drill (DD) holes and 6 Reverse Circulation (RC) holes (totalling 1,802m) completed at the NE Bankan prospect, with drilling intersecting good to high-grade gold at depth.
- Best intersections include:
- BNERD009: 51m @ 1.4g/t Au from 161m, and 14m @ 7.2g/t Au from 217m, incl. 3m @ 24.8g/t Au from 222m, and 1m @12.3g/t Au from 228m Hole ended in gold mineralisation (2.6m @ 3.1g/t Au from 318m to end of hole)
- BNERC0053: 38m @ 1.7g/t Au from 1m, incl. 1m @ 15.7g/t Au from 13m
- BNERC0052: 11m @ 3.0g/t Au from 43m, incl. 1m @ 25.4g/t Au from 46
- BNERD0051W: 68m @ 0.7g/t Au from 49m
Click here to read the full ASX Announcement.
About Predicitive Discovery Limited (ASX: PDI)
Predictive Discovery (ASX:PDI) is an ASX listed West African gold explorer currently progressing its 100%-owned Bankan Project located in the prolific Siguiri Basin in Guinea.
Over the past 11 months, the Company has made two significant greenfield gold discoveries at Bankan, NE Bankan and Bankan Creek. First phase drilling at the NE Bankan prospect which was first discovered in April 2020, outlined a 1.6km long zone of shallow gold mineralisation, with steadily increasing RC/DD drill coverage at depth now taking place. At Bankan Creek the Company has identified a potential satellite deposit 3km to the west of NE Bankan that has only been lightly tested but which bears the hallmarks of a strong gold mineralised system.
The results to date demonstrate that NE Bankan has the potential to be a plus-million-ounce gold system, with broad zones of gold consistently intersected over a growing strike length. Following completion of the ongoing RC and DD drilling program, infill drilling will be carried out to support the Maiden Resource Estimate planned for mid-2021 with metallurgical test work is scheduled to begin in April 2021.
Predictive also holds assets in Burkina Faso and joint venture gold projects within Cote D’Ivoire.
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
